Active Surveillance for Low-Risk Prostate Cancer

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE UROLOGIE | 2024年 / 55卷 / 06期
关键词：
D O I：
10.1055/a-2321-2153
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
For patients with low-risk prostate cancer, active surveillance is the preferred therapy. Studies on highly selective patient groups show excellent results from this strategy in terms of oncological prognosis, but long-term data at the population level are still lacking. A study from Canada now closes this knowledge gap.
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [42] Low-Risk Prostate Cancer Patients on Active Surveillance: Utility of Immunohistochemistry
    Poveda, J.
    Eldefrawy, A.
    Umar, S.
    Soloway, M.
    Jorda, M.
    LABORATORY INVESTIGATION, 2013, 93 : 241A - 241A
  • [43] ELEVEN YEARS' EXPERIENCE OF ACTIVE SURVEILLANCE OF LOW-RISK PROSTATE CANCER
    Alvisi, Maria Francesca
    Palorini, Federica
    Badenchini, Fabio
    Rancati, Tiziana
    Avuzzi, Barbara
    Bedini, Nice
    Bellardita, Lara
    Biasoni, Davide
    Catanzaro, Mario
    Colecchia, Maurizio
    De Luca, Letizia
    Donegani, Simona
    Dordoni, Paola
    Magnani, Tiziana
    Marenghi, Cristina
    Delor, Julia Paola Menichetti
    Morlino, Sara
    Paolini, Biagio
    Stagni, Silvia
    Tesone, Antonio
    Torelli, Tullio
    Baldoin, Edoardo Tulli
    Villa, Sergio
    Villa, Silvia
    Zaffaroni, Nadia
    Nicolai, Nicola
    Salvioni, Roberto
    Valdagni, Riccardo
    ANTICANCER RESEARCH, 2017, 37 (04) : 2115 - 2117
  • [44] Active Surveillance for the Management of Low-Risk Prostate Cancer in a Japanese Cohort
    Takeda, H.
    Nakano, Y.
    Kashiwagi, Y.
    Kojima, I
    Takai, S.
    Fujita, T.
    UROLOGY, 2012, 80 (03) : S292 - S293
  • [45] Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance
    Ho, Matthew D.
    Ross, Ashley E.
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 38 - 45
  • [46] Active Surveillance of Low-Risk Thyroid Cancer
    Zanocco, Kyle A.
    Hershman, Jerome M.
    Leung, Angela M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (20): : 2020 - 2021
  • [47] Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Dall'Era, Marc A.
    Konety, Badrinath R.
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (05): : 277 - 283
  • [48] Active surveillance in men with low-risk prostate cancer: current and future challenges
    Han, Christopher Sejong
    Parihar, Jaspreet Singh
    Kim, Isaac Yi
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2013, 1 (01): : 72 - 82
  • [49] Active surveillance for low-risk bladder cancer
    Tiu, Albert
    Jenkins, Lawrence C.
    Soloway, Mark S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 33.e7 - 33.e10
  • [50] Intensity of Active Surveillance and Transition to Treatment in Men with Low-risk Prostate Cancer
    Olsson, Henrik
    Nordstrom, Tobias
    Clements, Mark
    Gronberg, Henrik
    Lantz, Anna Wallerstedt
    Eklund, Martin
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (05): : 640 - 647
12345